COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX

被引：0
|
作者：
Waclawiczek, A. [1 ,2 ]
Leppa, A. [1 ,2 ]
Renders, S. [1 ,2 ,3 ]
Stumpf, K. [1 ,2 ]
Reyneri, C. [1 ,2 ]
Betz, B. [1 ,2 ]
Janssen, M. [3 ]
Shahswar, R. [4 ]
Donato, E. [1 ,2 ]
Unglaub, J. M. [3 ]
Schlenk, R. F. [3 ]
Hundemer, M. [3 ]
Pabst, C. [3 ]
Heuser, M. [4 ]
Raffel, S. [3 ]
Mueller-Tidow, C. [3 ]
Sauer, T. . [3 ]
Trumpp, A. [1 ,2 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] HiSTEM GmbH, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Heidelberg, Germany
[4] Hannover Med Sch, Hannover, Germany
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
41
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
    Waclawiczek, Alexander
    Leppae, Aino-Maija
    Renders, Simon
    Stumpf, Karolin
    Reyneri, Cecilia
    Betz, Barbara
    Janssen, Maike
    Shahswar, Rabia
    Donato, Elisa
    Karpova, Darja
    Thiel, Vera
    Unglaub, Julia M.
    Grabowski, Susanna
    Gryzik, Stefanie
    Vierbaum, Lisa
    Schlenk, Richard F.
    Roellig, Christoph
    Hundemer, Michael
    Pabst, Caroline
    Heuser, Michael
    Raffel, Simon
    Mueller-Tidow, Carsten
    Sauer, Tim
    Trumpp, Andreas
    CANCER DISCOVERY, 2023, 13 (06) : 1408 - 1427
  • [2] HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    M Kontro
    A Kumar
    M M Majumder
    S Eldfors
    A Parsons
    T Pemovska
    J Saarela
    B Yadav
    D Malani
    Y Fløisand
    M Höglund
    K Remes
    B T Gjertsen
    O Kallioniemi
    K Wennerberg
    C A Heckman
    K Porkka
    Leukemia, 2017, 31 : 301 - 309
  • [3] HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    Kontro, M.
    Kumar, A.
    Majumder, M. M.
    Eldfors, S.
    Parsons, A.
    Pemovska, T.
    Saarela, J.
    Yadav, B.
    Malani, D.
    Floisand, Y.
    Hoglund, M.
    Remes, K.
    Gjertsen, B. T.
    Kallioniemi, O.
    Wennerberg, K.
    Heckman, C. A.
    Porkka, K.
    LEUKEMIA, 2017, 31 (02) : 301 - 309
  • [4] Tumor gene expression patterns affecting response to BCl-2 inhibitor venetoclax in acute myeloid leukemia
    Garay, Juan Antonio Raygoza
    Yun, Seongseok
    Osman, Afaf
    Ramlal, Reshma
    Feith, David
    Churchman, Michelle
    Dhakal, Prajwal
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia
    Wang, Xiangmeng
    Mak, Po Yee
    Mu, Hong
    Tao, Wenjing
    Rao, Arvind
    Visweswaran, Ravikumar
    Ruvolo, Vivian
    Pachter, Jonathan A.
    Weaver, David T.
    Andreeff, Michael
    Xu, Bing
    Carter, Bing Z.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1636 - 1648
  • [6] Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
    Daniel A. Pollyea
    Brett M. Stevens
    Courtney L. Jones
    Amanda Winters
    Shanshan Pei
    Mohammad Minhajuddin
    Angelo D’Alessandro
    Rachel Culp-Hill
    Kent A. Riemondy
    Austin E. Gillen
    Jay R. Hesselberth
    Diana Abbott
    Derek Schatz
    Jonathan A. Gutman
    Enkhtsetseg Purev
    Clayton Smith
    Craig T. Jordan
    Nature Medicine, 2018, 24 : 1859 - 1866
  • [7] Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
    Pollyea, Daniel A.
    Stevens, Brett M.
    Jones, Courtney L.
    Winters, Amanda
    Pei, Shanshan
    Minhajuddin, Mohammad
    D'Alessandro, Angelo
    Culp-Hill, Rachel
    Riemondy, Kent A.
    Gillen, Austin E.
    Hesselberth, Jay R.
    Abbott, Diana
    Schatz, Derek
    Gutman, Jonathan A.
    Purev, Enkhtsetseg
    Smith, Clayton
    Jordan, Craig T.
    NATURE MEDICINE, 2018, 24 (12) : 1859 - +
  • [8] Combinatorial BCL-2/ BCL2L1 Expression Predicts Clinical Response to Ruxolitinib in Myelofibrosis
    Coltro, Giacomo
    Videschi, Viola
    Gesullo, Francesca
    Balliu, Manjola
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    BLOOD, 2023, 142
  • [9] High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
    Tóthová, E
    Fricová, M
    Stecová, N
    Kafková, A
    Elbertová, A
    NEOPLASMA, 2002, 49 (03) : 141 - 144
  • [10] Clinical and Molecular Features of Highly Durable Response to Azacitidine plus Venetoclax in Acute Myeloid Leukemia
    Hayden, Alexander
    Bosma, Grace
    Gutman, Jonathan A.
    Amaya, Maria L.
    Abbott, Diana
    Smith, Clayton
    Stevens, Brett M.
    Jordan, Craig T.
    Pollyea, Daniel A.
    McMahon, Christine M.
    BLOOD, 2022, 140 : 9163 - 9164
12345